Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Dec;110(4):1317-20.
doi: 10.1111/j.1476-5381.1993.tb13962.x.

The action of Hoe 140 on the bradykinin-induced splenic pressor reflex of the anaesthetized cat

Affiliations

The action of Hoe 140 on the bradykinin-induced splenic pressor reflex of the anaesthetized cat

J B Louttit et al. Br J Pharmacol. 1993 Dec.

Abstract

1. Intrasplenic injection of bradykinin (BK) induced a dose-dependent pressor response in the anaesthetized cat, with an ED50 of 0.98 +/- 0.43 nmol. In contrast, intrasplenic administration of desArg9bradykinin (desArg9BK) was without significant effect at doses of up to 200 nmol. 2. Intravenously administered BK induced a dose-dependent depressor response in the anaesthetized cat, with an ED50 of 0.86 +/- 0.09 nmol kg-1. desArg9BK was again without significant effect in this system at doses of up to 200 nmol kg-1. 3. Both the pressor and depressor responses to BK were antagonized to a similar degree in a dose-dependent manner by Hoe 140 (10 and 100 nmol kg-1, i.v.). 4. At these doses, Hoe 140 appears to be a specific BK antagonist as it was ineffective against pressor responses to intrasplenic injection of capsaicin (5 nmol), while blocking those to an approximately equieffective dose of BK (1 nmol) in a dose-dependent fashion. 5. Both the pressor response to intrasplenic BK and the depressor response to intravenous BK in the anaesthetized cat appear to be mediated by B2-receptors. This model may be useful in the quantitative determination of the antinociceptive potency of BK antagonists.

PubMed Disclaimer

Similar articles

References

    1. Br J Pharmacol Chemother. 1968 Feb;32(2):330-8 - PubMed
    1. Arch Int Pharmacodyn Ther. 1962 Apr 1;136:353-84 - PubMed
    1. Pharmacol Rev. 1980 Mar;32(1):1-46 - PubMed
    1. Am J Physiol. 1984 Nov;247(5 Pt 2):R856-65 - PubMed
    1. Eur J Pharmacol. 1985 Aug 7;114(1):9-21 - PubMed

LinkOut - more resources